Role of IGFBP-3 in the regulation of β-cell mass during obesity: Adipose tissue/β-cell cross talk

Endocrinology

Volumn 153, Issue 1, 2012, Pages 177-187

  Palau, Nuria ^a   Rebuffat, Sandra A ^a,b   Altirriba, Jordi ^a,b   Piquer, Sandra ^a,b   Hanzu, Felicia A ^b   Gomis, Ramon ^a,b   Barbera, Albert ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL PROLIFERATION; DIET; GENE EXPRESSION; MALE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; CELL COUNT; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; DIET; DISEASE MODELS, ANIMAL; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-SECRETING CELLS; MALE; OBESITY; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RNA, MESSENGER;

EID: 84455191521     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0181     Document Type: Article

References (40)

1. Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR 1997 Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572 (Pubitemid 27154421)
2. Butler AE, Janson J, Soeller WC, Butler PC 2003 Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 52:2304-2314 (Pubitemid 37059501)
3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP 2001 The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195-1200 (Pubitemid 33015548)
4. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110 (Pubitemid 36042113)
5. Bonner-Weir S 2000 Perspective: postnatal pancreatic β cell growth. Endocrinology 141:1926-1929 (Pubitemid 32274338)
6. Dor Y, Brown J, Martinez OI, Melton DA 2004 Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46 (Pubitemid 38620543)
7. Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, Hara A, Toyoda Y, Miwa I, Aizawa S, Tsutsumi S, Tsubamoto Y, Hashimoto S, Eto K, Nakamura A, Noda M, Tobe K, Aburatani H, Nagai R, Kadowaki T 2007 Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 117:246-257 (Pubitemid 46048470)
8. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M, Kulkarni RN 2007 Insulin receptors in β-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 104:8977-8982 (Pubitemid 47175422)
9. Assmann A, Ueki K, Winnay JN, Kadowaki T, Kulkarni RN 2009 Glucose effects on β-cell growth and survival require activation of insulin receptors and insulin receptor substrate 2. Mol Cell Biol 29:3219-3228
10. Trayhurn P 2005 Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184:285-293 (Pubitemid 41039735)
11. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (Pubitemid 38766330)
12. Marques BG, Hausman DB, Martin RJ 1998 Association of fat cell size and paracrine growth factors in development of hyperplastic obesity. Am J Physiol 275:R1898-R1908
13. Claret M, Corominola H, Canals I, Saura J, Barcelo-Batllori S, Guinovart JJ, Gomis R 2005 Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 146:4362-4369 (Pubitemid 41324032)
14. Merglen A, Theander S, Rubi B, Chaffard G, Wollheim CB, Maechler P 2004 Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology 145:667-678 (Pubitemid 38183809)
15. Altirriba J, Barbera A, Del Zotto H, Nadal B, Piquer S, Sánchez-Pla A, Gagliardino JJ, Gomis R 2009 Molecular mechanisms of tungstate- induced pancreatic plasticity: a transcriptomics approach. BMC Genomics 10:406
16. Fernández-Alvarez J, Barber à A, Nadal B, Barceló -Batllori S, Piquer S, Claret M, Guinovart JJ, Gomis R 2004 Stable and functional regeneration of pancreatic β-cell population in nSTZ-rats treated with tungstate. Diabetologia 47:470-477
17. Marzo N, Mora C, Fabregat ME, Martín J, Usac EF, Franco C, Barbacid M, Gomis R 2004 Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased βcell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic β cell mass regeneration in type 1 diabetes. Diabetologia 47:686-694 (Pubitemid 38658371)
18. Prats E, Monfar M, Castell à J, Iglesias R, Alemany M 1989 Energy intake of rats fed a cafeteria diet. Physiol Behav 45:263-272 (Pubitemid 19098558)
19. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T 2000 Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49:1880-1889
20. Cousin SP, Hugl SR, Myers MG Jr, White MF, Reifel-Miller A, Rhodes CJ 1999 Stimulation of pancreatic β-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no cross talk to insulin receptor substrate-mediated mitogenic signalling. Biochem J 344(Pt 3):649-658 (Pubitemid 30036999)
21. Hügl SR, White MF, Rhodes CJ 1998 Insulin-like growth factor I (IGF-I)-stimulated pancreatic β-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 cells. J Biol Chem 273:17771-17779 (Pubitemid 28355120)
22. Nielsen H, Brunak S, von Heijne G 1999 Machine learning approaches for the prediction of signal peptides and other protein sorting signals. Protein Eng 12:3-9 (Pubitemid 29050535)
23. Dastot F, Duquesnoy P, Sobrier ML, Goossens M, Amselem S 1998 Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein. Mol Cell Endocrinol 137:79-84 (Pubitemid 28185001)
24. Yamada PM, Lee KW 2009 Perspectives in mammalian IGFBP-3 biology: local vs. systemic action. Am J Physiol Cell Physiol 296:C954-C976
25. Barandier C, Montani JP, Yang Z 2005 Mature adipocytes and perivascular adipose tissue stimulate vascular smooth muscle cell proliferation: effects of aging and obesity. Am J Physiol Heart Circ Physiol 289:H1807-H1813 (Pubitemid 41507326)
26. Yin N, Wang D, Zhang H, Yi X, Sun X, Shi B, Wu H, Wu G, Wang X, Shang Y 2004 Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res 64:5870-5875 (Pubitemid 39095588)
27. Schinner S, Ulgen F, Papewalis C, Schott M, Woelk A, Vidal-Puig A, Scherbaum WA 2008 Regulation of insulin secretion, glucokinase gene transcription and β cell proliferation by adipocyte-derived Wnt signalling molecules. Diabetologia 51:147-154 (Pubitemid 50002200)
28. Pond CM, Mattacks CA 1998 In vivo evidence for the involvement of the adipose tissue surrounding lymph nodes in immune responses. Immunol Lett 63:159-167 (Pubitemid 28522303)
29. Greenberg AS, Obin MS 2006 Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83:461S-465S (Pubitemid 44713219)
30. Attallah H, Friedlander AL, Hoffman AR 2006 Visceral obesity, impaired glucose tolerance, metabolic syndrome, and growth hormone therapy. Growth Horm IGF Res 16(Suppl A):S62-S67
31. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW 1982 Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260
32. Kawano Y, Kypta R 2003 Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116:2627-2634
33. Baxter RC, Twigg SM 2009 Actions of IGF binding proteins and related proteins in adipose tissue. Trends Endocrinol Metab 20:499-505
34. Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ 2002 Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-α or EGF, augments pancreatic β-cell proliferation. Diabetes 51:966-976 (Pubitemid 34438338)
35. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F 2002 β Cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 109:1153-1163 (Pubitemid 34496593)
36. Petrik J, Pell JM, Arany E, McDonald TJ, Dean WL, Reik W, Hill DJ 1999 Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology 140:2353-2363 (Pubitemid 30636477)
37. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A 2001 The somatomedin hypothesis: 2001. Endocr Rev 22:53-74 (Pubitemid 32187803)
38. Yamada PM, Mehta HH, Hwang D, Roos KP, Hevener AL, Lee KW 2010 Evidence of a role for insulin-like growth factor binding protein (IGFBP)-3 in metabolic regulation. Endocrinology 151:5741-5750
39. Olsen TS 1978 Lipomatosis of the pancreas in autopsy material and its relation to age and overweight. Acta Pathol Microbiol Scand A 86A:367-373
40. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA 2008 Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 16:522-530 (Pubitemid 351328001)